Misplaced Pages

Rubella vaccine: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

Browse history interactively ← Previous edit Next edit →Content deleted Content addedVisual WikitextInline

Revision as of 04:21, 22 August 2011 editGoustien (talk \| contribs)Autopatrolled, Extended confirmed users45,923 edits added Category:Live vaccines using HotCat ← Previous edit		Revision as of 04:35, 22 August 2011 edit undoCheMoBot (talk \| contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - updated 'ChemSpiderID_Ref', 'DrugBank_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per [[Misplaced Pages:WikiProject Chemicals/Chembox validation\|Chem/DruNext edit →
Line 9:		Line 9:
	\| ATC_suffix = BJ01		\| ATC_suffix = BJ01
	\| PubChem =		\| PubChem =
			\| DrugBank_Ref = {{drugbankcite\|correct\|drugbank}}
	\| DrugBank =		\| DrugBank =
	\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->		\| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->

Revision as of 04:35, 22 August 2011

Pharmaceutical compound

Rubella vaccine
Vaccine description
Target	Rubella
Vaccine type	Attenuated
Clinical data
ATC code	J07BJ01 (WHO)
(verify)

Rubella vaccine is a vaccine used against rubella. One form is called "Meruvax".

See also

References

Josefson D (2001). "Rubella vaccine may be safe in early pregnancy". BMJ. 322 (7288): 695. PMC 1119900. PMID 11264203. {{cite journal}}: Unknown parameter |month= ignored (help)
Weibel RE, Caserta V, Benor DE, Evans G (1998). "Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program". Pediatrics. 101 (3 Pt 1): 383–7. doi:10.1542/peds.101.3.383. PMID 9481001. {{cite journal}}: Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)

v
t
e

Artificial induction of immunity / Immunization: Vaccines, Vaccination, Infection, Inoculation (J07)

Development

Classes

Conjugate
Inactivated
Live
- Attenuated
- Heterologous
Subunit/component / Peptide / Virus-like particle / Synthetic
DNA / mRNA
Therapeutic
Toxoid

Administration

Global:
- GAVI Alliance
- NITAG
- SAGE
- Vaccine wastage
- Policy
- Schedule
- Vaccine injury
US:

Vaccines

Bacterial	Anthrax Brucellosis Cholera Diphtheria Hib Leptospirosis Lyme disease Meningococcus MeNZB NmVac4-A/C/Y/W-135 Pertussis Plague Pneumococcal PCV PPSV Q fever Tetanus Tuberculosis BCG Typhoid Ty21a ViCPS Typhus combination: DPT/DTwP/DTaP Td/Tdap research: Clostridioides difficile Group B streptococcal disease Shigellosis
Viral	Adenovirus Chikungunya Ebola rVSV-ZEBOV Flu H1N1 (Pandemrix) H5N1 H5N8 LAIV Hantavirus Hepatitis A Hepatitis B Hepatitis E HPV Cervarix Gardasil Japanese encephalitis Measles Mpox Mumps Polio Sabin Salk Rabies Rotavirus Rubella SARS-CoV-2 Corbevax Bharat Biotech CanSino CoronaVac EpiVacCorona Janssen Kostaive Moderna Novavax Oxford–AstraZeneca Pfizer–BioNTech Sanofi–GSK Sinopharm BIBP Skycovione Sputnik V Valneva Respiratory syncytial virus (RSV) Smallpox Tick-borne encephalitis Varicella zoster Chicken pox Shingles Yellow fever combination: Hepatitis A and B MMR MMRV research: Cytomegalovirus Dengue Epstein–Barr virus Hepatitis C Herpes simplex HIV Zika
Protozoan	Malaria RTS,S research: Trypanosomiasis
Helminthiasis	research: Hookworm Schistosomiasis
Other	Androvax (androstenedione albumin) Cancer vaccines ALVAC-CEA BCG Hepatitis B HPV Cervarix Gardasil Prostvac NicVAX Ovandrotone albumin (Fecundin) TA-CD TA-NIC combination: DTaP-IPV/Hib DTaP-IPV-HepB DTwP-HepB-Hib Hexavalent vaccine

Inventors/
researchers

Controversy

Related

WHO-EM
Withdrawn from market
Clinical trials:
- Phase III
- Never to phase III